Results 251 to 260 of about 2,900,397 (306)

GLP-1 receptor agonists beyond glycemic control: integrated cardio-renal-metabolic protection across the cardiovascular kidney metabolic continuum. [PDF]

Cardiovasc Diabetol Endocrinol Rep
Elsayed A, Ayoub WJ, Elsayed N, Stephens J, Udongwo N, Elsayed Y, Ghali JK.   +6 more
europepmc   +1 more source

Is the Commitment to LDL-C Eternal? [PDF]

Methodist Debakey Cardiovasc J
Sniderman AD.
europepmc   +1 more source

Differential association of hypothyroidism with cardiovascular events and cardiovascular mortality: a systematic review and meta-analysis. [PDF]

Endocrine
Gatta E, Delbarba A, Vizzardi E, Rotondi M, Cappelli C.   +4 more
europepmc   +1 more source

Empagliflozin improves serum uric acid and early cardiometabolic outcomes in asymptomatic hyperuricemia among patients with type 2 diabetes: A 6-month observational study. [PDF]

Medicine (Baltimore)
Nguyen MQD, Tran KDD, Tran SK.
europepmc   +1 more source

Epigenetics in cardiovascular health, pathology, and development. [PDF]

Epigenetics
Szulik MW, Hortells L, Rosa-Garrido M.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Cardiovascular Ochronosis

Cardiovascular Pathology, 2020
In this review, we summarize previously reported case reports (n=66) in which the presence of ochronotic pigment was found in one or more cardiovascular structures either at necropsy or after operative excision of a cardiac valve or portions of arteries or both.
Nuvaira Ather, William C. Roberts
openaire   +2 more sources